Filing Details
- Accession Number:
- 0001209191-11-059456
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2011-12-05 15:56:01
- Reporting Period:
- 2011-12-01
- Filing Date:
- 2011-12-05
- Filing Date Changed:
- 2011-12-05
- Accepted Time:
- 2011-12-05 15:56:01
- Original Submission Date:
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1008848 | Acorda Therapeutics Inc | ACOR | Biological Products, (No Disgnostic Substances) (2836) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1272353 | David Lawrence | 15 Skyline Drive Hawthorne NY 10532 |
Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings |
|---|---|---|---|---|---|
| Common Stock | Disposition | 2011-12-01 | 9,896 | $22.92 | 16,249 |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- Sales pursuant to a 10b5-1 plan. These sales are primarily intended to cover the tax liability resulting from restricted stock vesting.
- The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $22.73 to $23.15 per share. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
Insider Monkey Small Cap Strategy
Insider Monkey beat the market by 20 percentage points in 6 months - Learn how!
